Home >> Blog >> Chandan Healthcare IPO GMP, Price, Date & Complete Details
Chandan Healthcare IPO GMP, Price, Date & Complete Details
![Chandan Healthcare IPO GMP, Price, Date & Complete Details](../admin/media/Chandan-Healthcare-ipo.png)
Table of Contents
- Chandan Healthcare IPO-Complete Overview
- Chandan Healthcare IPO Overview
- Company Financial
- The Objective of The Issue
- Peers of Chandan Healthcare Ltd.
- Evaluation
- IPO's Strengths
- Weaknesses of the IPO
- Chandan Healthcare IPO GMP
- Promoters And Management of Chandan Healthcare Ltd.
- IPO Lead Managers
- Dividend Policy
- Conclusion
Chandan Healthcare IPO-Complete Overview
Chandan Healthcare IPO under the SME IPO category is a book-build issue of Rs.107.36 Cr (67,52,000 Shares) by Chandan Healthcare Limited, which was incorporated in September 2003. It opened diagnostic centers with pathology and radiology services in Northern India.
As of 31st December 2024, the company has one flagship lab, seven central labs, twenty-six satellite centers, and over 300 collection centers in more than 23 cities of Uttar Pradesh and over 19 cities of Uttarakhand. The company performs 1,496 distinct tests in different specialties. The test menu comprises:
481 regular biochemistry and/or hematological pathology tests basic 1,015 specialized tests such as immunohistopathology and molecular pathology, and 545 radiological x-rays, ultrasound, CT, MRI, and specialized CT scan examinations.
The radiology facilities include at least eleven CT scan machines and a minimum of four MRI machines.
Goods and services provided:
The main type of activity is related to conducting diagnostics, with the occasional sale of consumable items such as X-ray films and reagents. In Chandan Pharmacy Limited, which is a subsidiary, retail medical stores are serviced by pharmacists.
-
Routine Pathology Testing
-
Special Pathology Testing
-
Radiology Pathology Testing
-
Preventive and Wellness Services
-
Home Collection Service.
Chandan Healthcare IPO Overview
This Chandan Healthcare IPO date is 10 February 2025, and its ‘initial public offering’ will end on 12 February 2025.
This Rs.107.36 crore new SME IPO comprises a fresh issue of 44.52 lac Shares (Rs.70.79 Cr) and an offer for sale of 23 lac Shares (Rs.36.57 Cr).
This upcoming IPO date is on 10 Feb 2025. The Chandan Healthcare IPO Price is Rs.151 to Rs.159 for each Share.
The expected IPO listing date is 17 Feb 2025, and the listing at NSE and SME.
The GMP of current IPOs can be viewed on our Live IPO GMP page, where you can get the current SME IPO GMP of all open IPOs.
Click to open a Demat account and apply for the IPO.
Company Financial
(Amount in Cr)
Period |
31 Dec 2024 |
31 Mar 2024 |
31 Mar 2023 |
Total Assets |
170.06 |
128.86 |
97.83 |
Total Revenue |
167.99 |
177.96 |
137.03 |
PAT |
17.42 |
16.36 |
3.59 |
Net Worth |
- |
41.09 |
27.3 |
Reserves & Surplus |
34.31 |
21.16 |
7.37 |
Borrowings |
51.92 |
42.01 |
21.36 |
Cash Flows
The cash flows for various activities are mentioned below:
(Amount in lac)
Net Cash Flow In Multiple Activities |
31 Dec 2024 |
31 Mar 2024 |
31 Mar 2023 |
Net Cash Flow Operating Activities |
2,559.41 |
246.31 |
449.78 |
Net Cash Flow Investing Activities |
(2,417.50) |
(1,482.73) |
(648.96) |
Net Cash Flow Financing Activities |
375.99 |
1556.60 |
246.01 |
Industry-wise Revenue Breakdown
(Amount in lac)
Particulars |
31 Dec 2024 |
31 Mar 2024 |
31 Mar 2023 |
Healthcare and cosmetic |
5,798.58 |
6,993.25 |
5,719.91 |
B2C |
6,312.15 |
6,027.02 |
4,339.87 |
Government |
4,384.27 |
4,213.17 |
2828.56 |
Automobile |
9.28 |
91.05 |
6.47 |
Banking, Financial Services, and Insurance |
119.05 |
88.73 |
128.73 |
Institution and College |
11.01 |
68.78 |
541.62 |
Information Technology |
7.48 |
65.99 |
35.19 |
Travel Tourism |
41.02 |
49.23 |
45.65 |
Food and Beverages |
12.05 |
22.20 |
8.77 |
Power |
5.12 |
14.01 |
4.94 |
Real Estate |
3.34 |
6.66 |
7.71 |
Petrochemical |
4.08 |
6.54 |
17.15 |
Retail |
30.73 |
2.83 |
1.02 |
Cement |
4.54 |
2.54 |
2.37 |
Entertainment, Media, Advertising and Events |
2.48 |
- |
|
Hotel |
2.18 |
5.01 |
0.39 |
Telecom |
0.09 |
0.05 |
0.28 |
Agro-Chemicals |
- |
1.08 |
0.31 |
Sugar |
- |
0.87 |
- |
State-wise Revenue Breakdown
(Amount in lac)
Particulars |
31 Dec 2024 |
31 Mar 2024 |
31 Mar 2023 |
Uttar Pradesh |
11,730.32 |
11,961.73 |
9,446.93 |
Uttarakhand |
4,977.42 |
5,697.28 |
4,242.01 |
Rajasthan |
37.85 |
- |
- |
Delhi |
1.89 |
- |
- |
Total |
16,747.47 |
17,659.01 |
13,688.94 |
(Source: RHP)
The Objective of The Issue
-
Establishing a new Flagship Diagnostic Center in Jankipuram, Uttar Pradesh's Lucknow.
-
Setting up a new Central Reference lab in Uttar Pradesh's Ayodhya.
-
Setting up a new Central Reference lab in Ashiyana, Uttar Pradesh's Lucknow.
-
General corporate purposes.
Peers of Chandan Healthcare Ltd.
Company Name |
Face Value (Rs.) |
EPS (Rs.) |
P/E (x) |
Vijaya Diagnostic Centre Limited |
1 |
11.62 |
87.75 |
Dr. Lal Pathlabs Ltd. |
10 |
46.25 |
62.34 |
Metropolis Healthcare Ltd. |
2 |
24.95 |
72.18 |
Evaluation
The IPO price is Rs.151 to Rs.159 for each Share.
Evaluation of P/E Ratio
Considering the FY ended 31 Mar 2024 with an EPS of Rs.8.14 from the last year, the resulting P/E ratio is 19.53x.
Considering the weighted EPS of Rs.4.54 for the last three years, the P/E ratio is 35.02x.
Comparative Analysis With Listed Peers
The average P/E Ratio of the industry is 75.05x.
Particulars |
P/E Ratio (x) |
Highest |
87.75 |
Lowest |
62.34 |
Average |
75.05 |
In simple words, the P/E ratio of this IPO (19.53x), compared with the industry’s average P/E of 75.05x, has an undervaluation (on a P/E ratio basis only). Hence the price of the Share seems fully priced for the investors when considered based on the average P/E ratio of the industry.
IPO's Strengths
-
A strong regional presence in Uttarakhand comprises 39 tier-two cities and towns.
-
Integrating diagnostics with pathology and radiology testing with medical consultations.
-
The Group has consistently generated revenue and profits, thus maintaining positive financial performance.
-
The Management considers this business as a matter of focus and therefore, they are highly experienced within the sector.
Weaknesses of the IPO
-
Any disruption to the primary diagnostic centers will hinder the conducting of diagnostic tests, which will have negative repercussions on the business as a whole.
-
If the brand name and brand image are not sustained and built upon, the Company and its business prospects will suffer detrimentally.
-
The company depends on B2C and some other clients for a significant portion of its earnings.
Chandan Healthcare IPO GMP
Chandan Healthcare IPO GMP is Rs.0 as of 05 Feb 2025.
IPO Timetable (Tentative)
The IPO date is February 10, with allotment on February 13, refund initiation on February 14, and listing on 17 February 2025.
Events |
Date |
IPO Opening Date |
Feb 10, 2025 |
IPO Closing Date |
Feb 12, 2025 |
IPO Allotment Date |
Feb 13, 2025 |
Refund Initiation |
Feb 14, 2025 |
IPO Listing Date |
Feb 17, 2025 |
Chandan Healthcare IPO Details
The IPO with a Face Value of Rs.10 per share offers a total issue size of 67,52,000 Shares (Rs.107.36 Cr).
IPO Opening & Closing date |
February 10, 2025 to February 12, 2025 |
Face Value |
Rs.10 per Share |
Issue Price |
Rs.151 to Rs.159 per Share. |
Lot Size |
800 Shares |
Issue Size |
67,52,000 Shares (Rs.107.36 Cr) |
Offer for Sale |
22,99,936 Shares (Rs.36.57 Cr) |
Fresh Issue |
44,52,064 Shares (Rs.70.79 Cr) |
Listing at |
NSE, SME |
Issue Type |
Book Build Issue IPO |
Registrar |
Kfin Technologies Limited |
Chandan Healthcare IPO Lot Details
The Chandan Healthcare Energy Limited IPO allows retail investors to invest in a minimum and maximum of 1 Lot (800 Shares) amounting to Rs.1,27,200 and in multiples thereof, while for HNI investors, the minimum Lot is 2 (1600 Shares) amounting to Rs.2,54,400.
Minimum Lot Investment (Retail) |
1 Lot |
Maximum Lot Investment (Retail) |
1 Lot |
HNI (Min) |
2 Lots |
IPO Reservation (% of Net Issue)
Institutional’s Portion |
50% |
Retail’s Portion |
35% |
Non - Institutional’s Portion |
15% |
Promoters And Management of Chandan Healthcare Ltd.
-
Amaranita Holdings (India) Private Limited
-
Amar Singh
-
Asmita Singh
-
Alok Singh
-
Shaleen Solanki
-
Vijay Singh
-
Vinay Lamba.
Pre-Issue Promoter Shareholding |
69.96% |
Post-Issue Promoter Shareholding |
- |
IPO Lead Managers
Unistone Capital Pvt Ltd.
Dividend Policy
The company has paid a total dividend of Rs.300 lac in FY2024.
Conclusion
Chandan Healthcare IPO is an opportunity for the company with a significant presence in UP and Uttarakhand in pathology and radiology services. The company has shown steady financial growth and profitability. Nevertheless, risks like brand dependency and operational disruption should be taken into consideration before investing.
Click Here To Stay Updated With The Upcoming IPOs.
DISCLAIMER: NOT a buy or sell recommendation. No investment or trading advice is given. The content is purely for educational and information purposes only. Always discuss with an eligible financial advisor before investing.
Finowings IPO Analysis
Hope you enjoyed the Finowings IPO Analysis. We tried our best to give every required detail about the company that you should know before applying to the IPO.
You must consult your financial advisor before making any financial decisions.
To Apply for the IPO, Click Here.
To Read the Prospectus of the Company Click Here to Download the DRHP.
DISCLAIMER: This is NOT any buy or sell recommendation. No investment or trading advice is given. The content is purely for educational and information purposes only. Always consult your eligible financial advisor for investment-related decisions.
Click Here to stay updated with the Upcoming IPOs.
Want to start Your Journey in stock market trading and investment? Join our Stock Market Class to become a beginner to expert trader! We cover everything from the basics of trading to advanced strategies for picking stocks. Plus, we're offering a special discount for women and students. Don't miss out - enroll now and kickstart your path to success in the stock market!
Open a world of Stock Market by Opening a Demat Account with your favorite Broking firm & Get a trading Strategy worth Rs.15,000!
Click here to open a Free Demat Account.
Thank You for reading this blog.
Hope you loved the IPO analysis.
Please Comment Below with your feedback because Your feedback motivates us to deliver more such content.
Follow MUKUL AGRAWAL for the latest IPO news and reviews. You can connect with us on social media platforms like Twitter, Facebook, and Instagram. You can also subscribe to our YouTube Channel for the latest videos of the stock.
Frequently Asked Questions
Rs.151 to Rs.159.
17 Feb 2025.
14 Feb 2025.